CareDx (CDNA) Tops Q1 EPS by 40c, provides guidance

CareDx (NASDAQ: CDNA) reported Q1 EPS of $0.34, $0.40 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $117.7 million versus the consensus estimate of $104.12 million.

GUIDANCE:

CareDx sees FY2026 revenue of $447-465 million, versus the consensus of $437.4 million.
The Company now expects full year 2026 adjusted EBITDA to be in the range of $43 million to $57 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Citi Upgrades Page Industries Ltd. (PAG:IN) to Buy, Opens Positive 90-Day Catalyst Watch
• BMW slashes profit margin forecast to 1-3%; JPMorgan calls cut "radical" as stock hits six-year low